Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    Open Studies | "Dengue"
Show Display Options
Rank Status Study
1 Recruiting TDENV PIV and LAV Dengue Prime-boost Strategy
Condition: Dengue
Interventions: Biological: TDENV-LAV;   Biological: TDENV-PIV 4 µg + alum adjuvant
2 Not yet recruiting Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
Condition: Dengue
Interventions: Biological: TetraVax-DV TV005;   Biological: Placebo
3 Recruiting Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2
Condition: Dengue
Interventions: Biological: Recombinant live attenuated trivalent dengue vaccine;   Biological: Placebo;   Biological: rDEN2Δ30-7169 vaccine
4 Recruiting Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV005;   Biological: rDEN3Δ30;   Biological: Placebo
5 Recruiting Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Condition: Dengue
Interventions: Biological: TV005 vaccine;   Biological: Placebo
6 Recruiting The Use of Biomarkers in Predicting Dengue Outcome
Condition: Dengue
Intervention:
7 Recruiting A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
Condition: Dengue
Intervention: Procedure: Blood sample collection
8 Recruiting An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Condition: Dengue
Interventions: Procedure: Blood sample collection;   Other: Data collection
9 Recruiting This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia
Condition: Dengue
Intervention: Procedure: Blood sample collection
10 Recruiting Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis
Condition: Dengue
Intervention: Device: SaniSal Oral Fluid Collector
11 Recruiting Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Condition: Dengue
Interventions: Biological: Dengue 1,2,3,4 (attenuated) vaccine;   Other: Placebo
12 Recruiting Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN1Δ30;   Biological: Placebo;   Biological: rDEN2Δ30-7169
13 Recruiting Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand
Condition: Dengue
Interventions: Biological: TV003;   Biological: Placebo for TV003
14 Recruiting Efficacy and Safety of Ivermectin Against Dengue Infection
Condition: Dengue Fever
Interventions: Drug: 2 days Ivermectin;   Drug: 3 days Ivermectin;   Drug: Placebo
15 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Other: case/control
16 Not yet recruiting Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
Condition: Dengue Fever
Interventions: Drug: Celgosivir;   Drug: Modipafant 50mg;   Drug: Placebo;   Drug: Modipafant 100mg
17 Recruiting Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou
Condition: Dengue Fever
Intervention:
18 Recruiting Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine (5 dose formulation);   Biological: Placebo, NaCl 0.9%
19 Recruiting Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults
Condition: Dengue
Intervention: Biological: TDENV-PIV with AS03B adjuvant. Placebo: 0.9% Sodium Chloride Solution.
20 Recruiting Ketotifen as a Treatment for Vascular Leakage During Dengue Fever
Conditions: Dengue Fever;   Pleural Effusion
Interventions: Drug: Ketotifen;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.